HMG-CoA Reductase Inhibitors (Paperback, Softcover reprint of the original 1st ed. 2002)

HMG-CoA reductase inhibitors (statins) are established drugs for the treatment of hypercholesterolemia. Furthermore, they induce regression of vascular atherosclerosis as well as reduction of cardiovascular-related morbidity and death in patients with and without coronary artery disease. This book deals with statins which have substantially altered the approach to therapy of atherosclerosis and its sequelae. Emphasis is placed on the scientific background to the discoveries and the development of the therapy, including an overview of the current state of knowledge of the drugs. Clinical data are reviewed extensively. This book not only provides the reader with valuable information but also stimulates further research into the pathogenesis of atherosclerosis and the mechanisms behind the action of effective statins. It sets the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating atherosclerosis and its sequelae. This topical volume...

General

Imprint:	Springer Basel
Country of origin:	Switzerland
Series:	Milestones in Drug Therapy
Release date:	October 2012
First published:	October 2012
Editors:	Gerd Schmitz • Michael Torzewski
Dimensions:	235 x 155 x 8mm (L x W x T)
Format:	Paperback
Pages:	151
Edition:	Softcover reprint of the original 1st ed. 2002
ISBN-13:	978-3-03-489451-7
Categories:	Books > Medicine > Nursing & ancillary services > Pharmacy / dispensing Promotions
LSN:	3-03-489451-1
Barcode:	9783034894517

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!